Bio-Techne
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	6/30/2022	6/30/2023	6/30/2024	6/30/2026	6/30/2027	6/30/2028
Revenue % change YoY	$1.10B N/A	$1.13B 2.81%	$1.15B 1.96%	Avg: $1.37B Low: $1.36B High: $1.39B avg. 19.02%	Avg: $1.52B Low: $1.50B High: $1.54B avg. 10.61%	Avg: $2.12B Low: $2.09B High: $2.14B avg. 39.26%
Net Income % change YoY	$272.05M N/A	$285.26M 4.85%	$168.10M -41.07%	Avg: $271.13M Low: $267.06M High: $275.15M avg. 61.29%	Avg: $343.08M Low: $335.75M High: $345.70M avg. 26.53%	Avg: $0 Low: $0 High: $0 avg. -100%
EBITDA % change YoY	$397.65M N/A	$460.56M 15.81%	$310.37M -32.61%	Avg: $383.66M Low: $378.68M High: $387.28M avg. 23.61%	Avg: $424.37M Low: $418.87M High: $428.38M avg. 10.61%	Avg: $591.01M Low: $583.34M High: $596.59M avg. 39.26%
EPS % change YoY	$1.73 N/A	$1.81 4.62%	$1.07 -40.88%	Avg: $1.67 Low: $1.65 High: $1.7 avg. 55.88%	Avg: $2.11 Low: $2.07 High: $2.14 avg. 26.49%	Avg: $0 Low: $0 High: $0 avg. -100%
Operating Expenses % change YoY	$459.90M N/A	$470.87M 2.38%	$563.03M 19.57%	Avg: $480.67M Low: $474.43M High: $485.21M avg. -14.62%	Avg: $531.68M Low: $524.78M High: $536.70M avg. 10.61%	Avg: $740.46M Low: $730.84M High: $747.45M avg. 39.26%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 29.27% in 2026-2028.

We have gathered data from 5 analysts. Their low estimate is 267.06M, average is 271.13M and high is 275.15M.

Wall Street analysts forecast annual average revenue growth of 22.96% in 2026-2028.

We have gathered data from 11 analysts. Their low revenue estimate is $1.36B, average is $1.37B and high is $1.39B.

Wall Street analysts forecast annual average earnings growth of 27.46% in 2026-2028.

We have gathered data from 5 analysts. Their low earnings per share estimate is $1.65, average is $1.67 and high is $1.7.

In the last twelve months analysts have been covering Bio-Techne stock. The most successful analyst is Catherine Schulte.